These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9381810)

  • 1. [A model of the depressive syndrome in rats induced by the neurotoxin MPTP and autoantibodies to serotonin and dopamine].
    Vetrilé LA; Krupina NA; Basharova LA; Kryzhanovskiĭ GN; Evseev VA; Orlova IN; Iordanskaia TE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(4):731-9. PubMed ID: 9381810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new model of an experimental depressive syndrome in rats induced by the systemic administration to the animals of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine].
    Kryzhanovskiĭ GN; Krupina NA; Kucherianu VG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(2):377-87. PubMed ID: 7597834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The electrical activity of the brain structures in an experimental depressive syndrome induced by the systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to rats].
    Krupina NA; Kryzhanovskiĭ GN; Iordanskaia TE; Orlova IN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(2):313-21. PubMed ID: 9644812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensorimotor reactivity (acoustic startle response) in rats with experimental depressive syndrome].
    Krupina NA; Orlova IN; Kryzhanovskiĭ GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(1):89-97. PubMed ID: 11253405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Krupina NA; Orlova IN; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1995 Jul; 120(7):66-70. PubMed ID: 8527787
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of spectral parameters of the rat brain electrical activity in the model of depressive pain syndrome].
    Pankova NB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2009; 59(4):495-505. PubMed ID: 19795813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
    Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
    J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of buspirone on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Krupina NA; Kryzhanovskiĭ GN; Orlova IN; Iordanskaia TE
    Biull Eksp Biol Med; 1996 May; 121(5):489-94. PubMed ID: 8744118
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new model of depressive syndrome in rats caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Kryzhanovskiĭ GN; Krupina NA; Kucherianu VG
    Biull Eksp Biol Med; 1995 Feb; 119(2):125-8. PubMed ID: 7670030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of parlodel on sleep-wakefulness cycle parameters in rats with experimental MPTP-induced depressive syndrome].
    Iordanskaia TE; Krupina NA; Kryzhanovskiĭ GN; Orlova IN
    Biull Eksp Biol Med; 1999 Apr; 127(4):380-3. PubMed ID: 10367116
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of melipramine on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Krupina NA; Orlova IN; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1995 Aug; 120(8):160-3. PubMed ID: 7579274
    [No Abstract]   [Full Text] [Related]  

  • 15. Count and phagocytic activity of leukocytes in rats with experimental depressive syndrome caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Krupina NA; Davydova TV; Fomina VG; Kryzhanovskii GN; Orlova IN
    Bull Exp Biol Med; 2000 Nov; 130(11):1041-4. PubMed ID: 11182810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters).
    Pankova NB; Vetrilé LA; Basharova LA; Krupina NA; Khlebnikova NN; Rodina VI; Kryzhanovskii GN
    Neurosci Behav Physiol; 2004 Feb; 34(2):131-8. PubMed ID: 15115320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies to glutamate, GABA, dopamine and serotonin in the dynamics of development of chronic brain epileptization in mice C578l/6].
    Vetrilé LA; Kuznetsova LV; Klishina NIu; Karpova MN
    Patol Fiziol Eksp Ter; 2010; (2):11-4. PubMed ID: 20804068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
    Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
    J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of autoantibodies to serotonin and catecholamines in chronically morphine addicted rats with manifestations of abstinence syndrome].
    Basharova LA; Evseev VA; Vetrilé LA; Trekova NA; Gamaleia NB; Veretinskaia AG; Tronnikov SI
    Biull Eksp Biol Med; 1993 May; 115(5):469-71. PubMed ID: 7913839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.